Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antibiotics"" wg kryterium: Temat


Starter badań:

Tytuł:
Usefulness of Xpert MTB/RIF Ultra for rapid diagnosis of extrapulmonary tuberculosis in Tunisia.
Autorzy:
Bouzouita I; National Reference Laboratory for Mycobacteria, LR19SP02, Abderahmane Mami pneumology hospital, Rue de l'hôpital, 2080, Ariana, Tunisia. .; Faculty of Mathematical, Physical and Natural Sciences of Tunis, University of Tunis El Manar, Campus Universitaire El Manar, 1068, Tunis, Tunisia. .
Ghariani A; National Reference Laboratory for Mycobacteria, LR19SP02, Abderahmane Mami pneumology hospital, Rue de l'hôpital, 2080, Ariana, Tunisia.; Faculty of Pharmacy, University of Monastir, Rue Ibn Sina 5000, Monastir, Tunisia.
Dhaou KB; National Reference Laboratory for Mycobacteria, LR19SP02, Abderahmane Mami pneumology hospital, Rue de l'hôpital, 2080, Ariana, Tunisia.; Faculty of Pharmacy, University of Monastir, Rue Ibn Sina 5000, Monastir, Tunisia.
Jemaeil S; National Reference Laboratory for Mycobacteria, LR19SP02, Abderahmane Mami pneumology hospital, Rue de l'hôpital, 2080, Ariana, Tunisia.
Essaalah L; National Reference Laboratory for Mycobacteria, LR19SP02, Abderahmane Mami pneumology hospital, Rue de l'hôpital, 2080, Ariana, Tunisia.
Bejaoui S; National Reference Laboratory for Mycobacteria, LR19SP02, Abderahmane Mami pneumology hospital, Rue de l'hôpital, 2080, Ariana, Tunisia.
Draoui H; National Reference Laboratory for Mycobacteria, LR19SP02, Abderahmane Mami pneumology hospital, Rue de l'hôpital, 2080, Ariana, Tunisia.
El Marzouk N; National Reference Laboratory for Mycobacteria, LR19SP02, Abderahmane Mami pneumology hospital, Rue de l'hôpital, 2080, Ariana, Tunisia.
Mehiri E; National Reference Laboratory for Mycobacteria, LR19SP02, Abderahmane Mami pneumology hospital, Rue de l'hôpital, 2080, Ariana, Tunisia.; Faculty of Pharmacy, University of Monastir, Rue Ibn Sina 5000, Monastir, Tunisia.
Slim-Saidi L; National Reference Laboratory for Mycobacteria, LR19SP02, Abderahmane Mami pneumology hospital, Rue de l'hôpital, 2080, Ariana, Tunisia.; Faculty of Pharmacy, University of Monastir, Rue Ibn Sina 5000, Monastir, Tunisia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 26; Vol. 14 (1), pp. 2217. Date of Electronic Publication: 2024 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Mycobacterium tuberculosis*/genetics
Tuberculosis, Extrapulmonary*
Antibiotics, Antitubercular*/pharmacology
Antibiotics, Antitubercular*/therapeutic use
Humans ; Tunisia ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021.
Autorzy:
Biset S; Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia. .
Teferi M; School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Alamirew H; School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Birhanu B; School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Dessie A; School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Aschale A; School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Haymanot A; School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Dejenie S; University of Gondar Comprehensive Specialized Hospital, University of Gondar, Gondar, Ethiopia.
Gebremedhin T; University of Gondar Comprehensive Specialized Hospital, University of Gondar, Gondar, Ethiopia.
Abebe W; Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Adane G; Department of Immunology and Molecular Biology, School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 22; Vol. 24 (1), pp. 238. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Antibiotics, Antitubercular*/therapeutic use
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Tuberculosis*/epidemiology
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/epidemiology
Tuberculosis, Multidrug-Resistant*/microbiology
Humans ; Aged ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Rifampin/pharmacology ; Rifampin/therapeutic use ; Retrospective Studies ; Ethiopia/epidemiology ; Drug Resistance, Bacterial
Czasopismo naukowe
Tytuł:
Effects of sputum bacillary load and age on GeneXpert and traditional methods in pulmonary tuberculosis: a 4-year retrospective comparative study.
Autorzy:
Li K; Department of Infectious Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West YantaRoad, Xi'an, Shaanxi Province, 710061, China.; Department of Infectious Diseases, Ankang Central Hospital, 85 South Jinzhou Road, Ankang, Shaanxi Province, 725000, China.
Hu Q; Laboratory of Molecular Pathology and Tuberculosis Diseases, Ankang Central Hospital, 85 South Jinzhou Road, Ankang, Shaanxi Province, 725000, China.
Liu J; Laboratory of Molecular Pathology and Tuberculosis Diseases, Ankang Central Hospital, 85 South Jinzhou Road, Ankang, Shaanxi Province, 725000, China.
Liu S; Department of Infectious Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West YantaRoad, Xi'an, Shaanxi Province, 710061, China.
He Y; Department of Infectious Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West YantaRoad, Xi'an, Shaanxi Province, 710061, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Nov 27; Vol. 23 (1), pp. 831. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*/genetics
Antibiotics, Antitubercular*/therapeutic use
Bacillus*
Tuberculosis, Pulmonary*/diagnosis
Tuberculosis, Pulmonary*/drug therapy
Humans ; Rifampin/pharmacology ; Rifampin/therapeutic use ; Retrospective Studies ; Sputum ; Sensitivity and Specificity ; Firmicutes
Czasopismo naukowe
Tytuł:
GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis.
Autorzy:
Rigouts L; Institute of Tropical Medicine, Mycobacteriology Unit, Nationalestraat 155, Antwerp, Belgium. .
Keysers J; Institute of Tropical Medicine, Mycobacteriology Unit, Nationalestraat 155, Antwerp, Belgium.
Rabab R; Institute of Tropical Medicine, Mycobacteriology Unit, Nationalestraat 155, Antwerp, Belgium.
Fissette K; Institute of Tropical Medicine, Mycobacteriology Unit, Nationalestraat 155, Antwerp, Belgium.
van Deun A; Independent Consultant, Louvain, Belgium.
de Jong BC; Institute of Tropical Medicine, Mycobacteriology Unit, Nationalestraat 155, Antwerp, Belgium.
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2023 Jul 14; Vol. 16 (1), pp. 146. Date of Electronic Publication: 2023 Jul 14.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis, Multidrug-Resistant*/diagnosis
Antibiotics, Antitubercular*/pharmacology
Antibiotics, Antitubercular*/therapeutic use
Humans ; Drug Resistance, Bacterial/genetics ; Rifampin/pharmacology ; Mutation ; Point Mutation ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Continuous surveillance of drug-resistant TB burden in Rwanda: a retrospective cross-sectional study.
Autorzy:
Habimana-Mucyo Y; Tuberculosis and Other Respiratory Communicable Diseases Division; HIV/AIDS, Disease Prevention and Control Department; Rwanda Biomedical Centre, Kigali, Rwanda.
Dushime A; Tuberculosis and Other Respiratory Communicable Diseases Division; HIV/AIDS, Disease Prevention and Control Department; Rwanda Biomedical Centre, Kigali, Rwanda.
Migambi P; Tuberculosis and Other Respiratory Communicable Diseases Division; HIV/AIDS, Disease Prevention and Control Department; Rwanda Biomedical Centre, Kigali, Rwanda.
Habiyambere I; Tuberculosis and Other Respiratory Communicable Diseases Division; HIV/AIDS, Disease Prevention and Control Department; Rwanda Biomedical Centre, Kigali, Rwanda.
Semuto Ngabonziza JC; National Reference Laboratory, Department of Biomedical Services, Rwanda Biomedical Centre, Kigali, Rwanda.; School of Medicine and Pharmacy, Department of Clinical Biology, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Decroo T; Unit of HIV and TB, Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Pokaż więcej
Źródło:
International health [Int Health] 2023 Jul 04; Vol. 15 (4), pp. 357-364.
Typ publikacji:
Journal Article
MeSH Terms:
Antibiotics, Antitubercular*/pharmacology
Antibiotics, Antitubercular*/therapeutic use
Mycobacterium tuberculosis*
Tuberculosis, Pulmonary*/drug therapy
Tuberculosis, Pulmonary*/epidemiology
Tuberculosis, Pulmonary*/diagnosis
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/epidemiology
Tuberculosis, Multidrug-Resistant*/diagnosis
Humans ; Rifampin/pharmacology ; Rifampin/therapeutic use ; Retrospective Studies ; Cross-Sectional Studies ; Drug Resistance, Bacterial ; Microbial Sensitivity Tests ; Rwanda/epidemiology
Czasopismo naukowe
Tytuł:
Doxorubicin-Mediated miR-433 Expression on Exosomes Promotes Bystander Senescence in Multiple Myeloma Cells in a DDR-Independent Manner.
Autorzy:
Vulpis E; Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Viale Regina Elena 291, 00161 Rome, Italy.
Cuollo L; Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Viale Regina Elena 291, 00161 Rome, Italy.
Borrelli C; Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Viale Regina Elena 291, 00161 Rome, Italy.
Antonangeli F; Institute of Molecular Biology and Pathology, National Research Council (CNR), 00161 Rome, Italy.
Masuelli L; Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Cippitelli M; Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Viale Regina Elena 291, 00161 Rome, Italy.
Fionda C; Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Viale Regina Elena 291, 00161 Rome, Italy.
Caracciolo G; Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Petrucci MT; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, 00161 Rome, Italy.
Santoni A; Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Viale Regina Elena 291, 00161 Rome, Italy.; IRCCS Neuromed, 86077 Pozzilli, Italy.
Zingoni A; Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Viale Regina Elena 291, 00161 Rome, Italy.
Soriani A; Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Viale Regina Elena 291, 00161 Rome, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Apr 06; Vol. 24 (7). Date of Electronic Publication: 2023 Apr 06.
Typ publikacji:
Journal Article
MeSH Terms:
Cellular Senescence*/drug effects
Bystander Effect*
Multiple Myeloma*/drug therapy
Multiple Myeloma*/genetics
Multiple Myeloma*/pathology
Doxorubicin*/pharmacology
Doxorubicin*/therapeutic use
Antibiotics, Antineoplastic*/pharmacology
Antibiotics, Antineoplastic*/therapeutic use
Topoisomerase II Inhibitors*/pharmacology
Topoisomerase II Inhibitors*/therapeutic use
Exosomes*/drug effects
Exosomes*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Humans ; Cell Line, Tumor ; DNA Damage ; Tumor Suppressor Protein p53/metabolism ; Cyclin-Dependent Kinase Inhibitor p21/metabolism
Czasopismo naukowe
Tytuł:
The Subcutaneous Administration of Beta-Lactams: A Case Report and Literary Review—To Do Small Things in a Great Way.
Autorzy:
Leanza, Gabriele Maria (AUTHOR)
Liguoro, Beatrice (AUTHOR)
Giuliano, Simone (AUTHOR)
Moreal, Chiara (AUTHOR)
Montanari, Luca (AUTHOR)
Angelini, Jacopo (AUTHOR)
Cai, Tommaso (AUTHOR)
Murri, Rita (AUTHOR)
Tascini, Carlo (AUTHOR)
Pokaż więcej
Źródło:
Infectious Disease Reports. Feb2024, Vol. 16 Issue 1, p93-104. 12p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies